BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miyahara LAN, Pontes FSC, Burbano RMR, Conte Neto N, Guimarães DM, Fonseca FP, Pontes HAR. PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma. Histopathology 2018;72:330-8. [DOI: 10.1111/his.13381] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Monteiro R, Hallikeri K, Sudhakaran A. PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis. J Oral Maxillofac Res 2021;12:e3. [PMID: 33959238 DOI: 10.5037/jomr.2021.12103] [Reference Citation Analysis]
2 Cerqueira JM, Pontes FS, Santos-Silva AR, Almeida OP, Costa RF, Fonseca FP, Gomez RS, Neto NC, Miyahara LA, Rodrigues-Fernandes CI, Neto ED, Araújo AL. Malignant transformation of oral leukoplakia: a multicentric retrospective study in Brazilian population. Med Oral Patol Oral Cir Bucal 2021;26:e292-8. [PMID: 33247570 DOI: 10.4317/medoral.24175] [Reference Citation Analysis]
3 Ling Z, Cheng B, Tao X. Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities. Int J Cancer 2021;148:1548-61. [PMID: 33091960 DOI: 10.1002/ijc.33352] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
4 Chaves FN, Bezerra TMM, Moraes DC, Costa SFDS, Silva PGB, Alves APNN, Costa FWG, Bernardes VF, Pereira KMA. Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma. Exp Mol Pathol 2020;112:104341. [PMID: 31730755 DOI: 10.1016/j.yexmp.2019.104341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Baghaei F, Abdollahi A, Mohammadpour H, Jahanbin M, Naseri Taheri F, Aminishakib P, Emami Razavi A, Kharazifard M. PTEN and miR-26b: Promising prognostic biomarkers in initiation and progression of Oral Squamous Cell Carcinoma. J Oral Pathol Med 2019;48:31-5. [DOI: 10.1111/jop.12794] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Nikolovski B, Monevska DP, Popovska M, Nikolovska VR, Minovska A. Assessment of Clinical Examination Validity in Oral Cancer Risk Patients. Balkan Journal of Dental Medicine 2020;24:38-44. [DOI: 10.2478/bjdm-2020-0006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Starzyńska A, Adamska P, Sejda A, Sakowicz-Burkiewicz M, Adamski ŁJ, Marvaso G, Wychowański P, Jereczek-Fossa BA. Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma? Life (Basel) 2020;10:E325. [PMID: 33287350 DOI: 10.3390/life10120325] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Pontes FSC, Pontes HAR, de Souza LL, de Jesus AS, Joaquim AMC, Miyahara LAN, Fonseca FP, Pinto Junior DS. Effect of 17-allylamino-17-demethoxygeldanamycin (17-AAG) on Akt protein expression is more effective in head and neck cancer cell lineages that retain PTEN protein expression. J Oral Pathol Med 2018;47:253-9. [PMID: 29297949 DOI: 10.1111/jop.12676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Prime SS, Cirillo N, Cheong SC, Prime MS, Parkinson EK. Targeting the genetic landscape of oral potentially malignant disorders has the potential as a preventative strategy in oral cancer. Cancer Lett 2021;518:102-14. [PMID: 34139286 DOI: 10.1016/j.canlet.2021.05.025] [Reference Citation Analysis]
10 Yan W, Wang Y, Chen Y, Guo Y, Li Q, Wei X. Exosomal miR-130b-3p Promotes Progression and Tubular Formation Through Targeting PTEN in Oral Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:616306. [PMID: 33829013 DOI: 10.3389/fcell.2021.616306] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]